Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: HK$2.68 M
• Last 3 months FTD volume: HK$2.78 M
• Last 12 months FTD volume: HK$30.57 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	HK$1.32 M	HK$17.08 M	🇺🇸 USA
Royalty Pharma RPRX	HK$0.16 B	HK$0.22 B	🇬🇧 UK
Palatin Technologies PTN	HK$0.2 M	HK$0.26 M	🇺🇸 USA
Eli Lilly LLY	HK$0.29 B	HK$0.42 B	🇺🇸 USA
AbbVie ABBV	HK$22.48 M	HK$0.10 B	🇺🇸 USA
Pfizer PFE	HK$29.26 M	HK$0.10 B	🇺🇸 USA
ANI Pharmaceuticals ANIP	HK$2.97 M	HK$6.57 M	🇺🇸 USA
Athersys ATHX	HK$0.09 M	HK$0.71 M	🇺🇸 USA